{"schema_version":"secwatch.filing_event.v1","accession":"0000728387-25-000013","form_type":"8-K","ticker":"CATX","cik":"0000728387","company_name":"Perspective Therapeutics, Inc.","filed_at":"2025-09-04T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.244862+00:00","generated_at":"2026-05-17T08:23:44.338843+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Perspective Therapeutics appoints Joel Sendek as CFO, replacing Juan Graham","bullets":["Effective Sept 4, 2025; Sendek brings over 30 years of biotech finance and equity research experience.","Sendek previously served as CFO at four biotech firms and raised over $2.5B in capital.","Compensation: $500k base salary, 40% target bonus, and 600,000 stock options vesting over 4 years.","No family relationships or material transactions with Sendek were reported.","Juan Graham will receive severance per his existing employment agreement upon signing a separation agreement."],"urls":{"canonical":"https://secwatch.observer/filing/0000728387-25-000013","json":"https://secwatch.observer/filing/0000728387-25-000013.json","markdown":"https://secwatch.observer/filing/0000728387-25-000013.md","text":"https://secwatch.observer/filing/0000728387-25-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/728387/000072838725000013/0000728387-25-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/728387/000072838725000013/catx-20250902.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T08:23:44.338843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}